Jerry J. Buccafusco
Affiliations: | Medical College of Georgia, Augusta, GA, United States |
Area:
Neuroscience Biology, Molecular Biology, Cell BiologyGoogle:
"Jerry Buccafusco"Mean distance: 26716.5
Children
Sign in to add trainee| Mary-Louise Risher | grad student | Georgia Regents University, Medical College of Georgia | |
| Ramamohana R. Jonnala | grad student | 2001 | Medical College of Georgia |
| Xinyu D. Li | grad student | 2007 | Medical College of Georgia |
| Ajay Sood | grad student | 2007 | Medical College of Georgia |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Webster SJ, Mruthinti S, Hill WD, et al. (2012) An aqueous orally active vaccine targeted against a RAGE/AB complex as a novel therapeutic for Alzheimer's disease. Neuromolecular Medicine. 14: 119-30 |
| Terry AV, Buccafusco JJ, Schade RF, et al. (2012) The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats. Biochemical Pharmacology. 83: 941-51 |
| Hall BJ, Pearson LS, Terry AV, et al. (2011) The use-dependent, nicotinic antagonist BTMPS reduces the adverse consequences of morphine self-administration in rats in an abstinence model of drug seeking. Neuropharmacology. 61: 798-806 |
| Webster SJ, Wilson CA, Lee CH, et al. (2011) The acute effects of dimebolin, a potential Alzheimer's disease treatment, on working memory in rhesus monkeys. British Journal of Pharmacology. 164: 970-8 |
| Terry AV, Buccafusco JJ, Gearhart DA, et al. (2011) Repeated, intermittent exposures to diisopropylfluorophosphate in rats: protracted effects on cholinergic markers, nerve growth factor-related proteins, and cognitive function. Neuroscience. 176: 237-53 |
| Terry AV, Buccafusco JJ, Herman EJ, et al. (2011) The prototypical ranitidine analog JWS-USC-75-IX improves information processing and cognitive function in animal models. The Journal of Pharmacology and Experimental Therapeutics. 336: 751-66 |
| Rueter LE, Rêlo AL, van Gaalen MM, et al. (2011) The use of the scopolamine-induced cognitive impairment model to translate on-target activity for ABT-894 from rodents/monkeys to humans: Preclinical evidences Biochemical Pharmacology. 82: 1043 |
| Kohlhaas KL, Robb H, Roderwald V, et al. (2011) α7 NNR allosteric modulation in behavioral models of cognition Biochemical Pharmacology. 82: 1042 |
| Millan MJ, Buccafusco JJ, Loiseau F, et al. (2010) The dopamine D3 receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 1035-51 |
| Bitner RS, Bunnelle WH, Decker MW, et al. (2010) In vivo pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107: preclinical considerations in Alzheimer's disease. The Journal of Pharmacology and Experimental Therapeutics. 334: 875-86 |